Anavex Life Sciences Corp (AVXL)

[Joseph_K]

Well, the Editor-in- Chief of the Journal of Alzheimer's Disease seems on board. There's a YouTube with Professor Grimmer (who's written about one million articles on Alzheimer's) about the trial (with the man who has the Anavex-informative website SOTC Analytics). Outside of AD, it's clear the scientists at the Michael J. Fox Foundation and at Cure Parkinson's think highly of blarcamesine. And read the post about Randi Hagerman's take on the efficacy of blarcamesine for Rett Syndrome patients that's at the top of this board's message list; google her, she's impressive.

Missling also hired recently the top (or among the top, I don't really know) CNS- disease biostatisticians from the FDA, who had to have a good idea of what our trials show, I would think.

You may need to wait for the peer-reviewed paper to be satisfied. My personal guess is that you will be. I'm betting on it, literally. :)